Erratum to: The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?

2024-9-14

<i>MGMT</i> promoter methylation and survival following chemotherapy for WHO grade 4 IDH-mutant astrocytoma

2024-9-11

Brain tumoroids: treatment prediction and drug development for brain tumors with fast, reproducible and easy-to-use personalized models

2024-9-10

Cognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy

2024-9-9

EGFR and EGFRvIII coopt host defense pathways, promoting progression in glioblastoma

2024-9-9

Corrigendum to: “Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis”

2024-9-2

Society News

2024-9-1

Activation of Wnt/β-catenin signaling is critical for the tumorigenesis of choroid plexus

2024-8-31

Multimodal Deep Learning Improves Recurrence Risk Prediction in Pediatric Low-Grade Gliomas

2024-8-30

Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survival

2024-8-30

ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in HER2-positive breast cancer

2024-8-30

cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas

2024-8-29

Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis

2024-8-29

The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma

2024-8-29

NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases

2024-8-29

Thrombosis, brain metastasis formation, and the perivascular metastatic niche—novel insights from the tumor microvascular circulation

2024-8-29

TLR agonists promote formation of Tertiary Lymphoid Structure and improve anti-glioma immunity

2024-8-27

Mapping Tumor Habitats in IDH-Wild Type Glioblastoma: Integrating MR Imaging, Pathologic, and RNA Data from Ivy Glioblastoma Atlas Project

2024-8-22

Distinct relapse pattern across molecular ependymoma types

2024-8-22

Corrigendum to: LY6K promotes glioblastoma tumorigenicity via CAV-1–mediated ERK1/2 signaling enhancement

2024-8-21

Enhancing neuro-oncology care through equity-driven applications of artificial intelligence

2024-8-19

The Emerging Field of Viroimmunotherapy for Pediatric Brain Tumors

2024-8-16

Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas

2024-8-10

IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma

2024-8-8

Defective autophagy of pericytes enhances radiation-induced senescence promoting radiation brain injury

2024-8-7

Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of EGFR mutated NSCLC patients developing leptomeningeal metastases: ORA-LM study

2024-8-7

Targeted radionuclide therapy for gliomas: emerging clinical trial landscape

2024-8-6

Defining Neuroblastoma: from origin to precision medicine

2024-8-5

Enhancing Prognostication and Treatment Response Evaluation in Primary CNS Lymphoma with 18F-FDG PET/CT

2024-8-4

RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation groups

2024-8-2

DPPA4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness

2024-8-2

A low level of tumor necrosis factor α in tumor microenvironment maintains the self-renewal of glioma stem cells by Vasorin-mediated glycolysis

2024-8-2

Postzygotic mosaicism of <i>SMARCB1</i> variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumors

2024-8-2

BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis

2024-8-2

Ongoing expansion of journal activities to meet the needs of stakeholders

2024-8-1

Forthcoming Meetings

2024-8-1

Tools and toys beyond RANO 2.0: digital flipbooks to monitor brain tumor growth dynamics?

2024-7-31

Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation

2024-7-31

Temozolomide Use in Elderly Patients with MGMT Promoter Unmethylated Glioblastoma: Is It Finally Time to Dismount a Dead Horse?

2024-7-31

A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients

2024-7-31

SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors

2024-7-29

Risk of new tumor, carotid stenosis, and stroke after Stereotactic Radiosurgery for Pituitary Tumor: A multicenter study of 2254 patients with imaging follow-up

2024-7-19

Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated BBB opening: A novel combinatorial immunotherapy regimen for gliomas

2024-7-19

Maternal obesogenic diet operates at the tumor cell of origin to increase incidence and decrease latency of Neurofibromatosis Type 1 optic pathway glioma

2024-7-18

Inhibition of PERK mediated UPR acts as a switch for reversal of residual senescence and as senolytic therapy in glioblastoma

2024-7-18

Erratum to: QOL-14. EPILEPTIC SEIZURES, ANTI-SEIZURE MEDICATIONS, AND NEUROCOGNITION IN SURVIVORS OF PEDIATRIC BRAIN TUMORS

2024-7-17

The morphology strikes back

2024-7-13

Targeting HTR2B suppresses non-functioning pituitary adenoma growth and sensitizes cabergoline treatment via inhibiting Gαq/PLC/PKCγ/STAT3 axis

2024-7-11

In Vivo Mouse Models for Adult Brain Tumors: Exploring Tumorigenesis and Advancing Immunotherapy Development

2024-7-11

Automated segmentation of brain metastases with deep learning: a multi-center, randomized crossover, multi-reader evaluation study

2024-7-11